Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg Sustainability Profile
Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg, commonly referred to as Ilapo, is a distinguished player in the pharmaceutical industry, headquartered in Germany. Founded in 1992, the company has established a strong presence in various operational regions across Europe, focusing on the development and distribution of high-quality medicinal products. Ilapo's core offerings include a diverse range of pharmaceuticals, with a particular emphasis on innovative formulations that cater to specific health needs. The company is recognised for its commitment to quality and efficacy, setting it apart in a competitive market. With a reputation for excellence, Ilapo has achieved significant milestones, solidifying its position as a trusted name in the healthcare sector.
DitchCarbon Score
How does Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg's reported carbon emissions
Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Ilapo may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company operates within the pharmaceutical sector, it is essential for them to consider industry standards and best practices in climate action to align with global sustainability goals.
How Carbon Intensive is Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg's Industry?
How Carbon Intensive is Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg's Location?
Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. Kg has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
